New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 22, 2012
09:46 EDTAUBN, CHS, CLH, CYH, FIRE, GRMN, MDCO, TXRH, WIREGappers report: Bullish gaps
This is a list of stocks making unusual moves on the open versus the prior day close. Gapping stocks often have excessive movements during the day and in the days thereafter. We use 5% for filter criteria and scanned for stocks that traded above $10 the prior day. GAPPING UP: WIRE 5.13%, CLH 5.26%, AUBN 5.57%, MDCO 8.11%, TXRH 9.26%, GRMN 9.71%, CYH 11.67%, CHS 13.35%, FIRE 17.09%.
News For AUBN;CHS;CLH;CYH;FIRE;GRMN;MDCO;TXRH;WIRE From The Last 14 Days
Check below for free stories on AUBN;CHS;CLH;CYH;FIRE;GRMN;MDCO;TXRH;WIRE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
10:00 EDTCHSOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:23 EDTCHSChico's FAS upgraded to Outperform from Market Perform at FBR Capital
FBR Capital upgraded Chico's FAS to Outperform citing shareholder return catalysts in 2014 and easy near-term same-store-sales compares. FBR raised its price target for the stock to $19 from $18.
April 14, 2014
10:02 EDTCYHOn The Fly: Analyst Upgrade Summary
Acorda Therapeutics (ACOR) upgraded to Outperform from Market Perform at FBR Capital... Allegheny Technologies (ATI) upgraded to Neutral from Underperform at Sterne Agee... BP (BP) upgraded to Buy from Hold at Canaccord... Bloomin' Brands (BLMN) upgraded to Buy from Hold at Deutsche Bank... Boardwalk Pipeline (BWP) upgraded to Neutral from Underperform at BofA/Merrill... Boston Scientific (BSX) upgraded at BofA/Merrill... Charles Schwab (SCHW) upgraded to Buy from Neutral at UBS... Citigroup (C) upgraded to Hold from Sell at Rafferty Capital... Community Health (CYH) upgraded to Outperform from Perform at Oppenheimer... Eaton Vance (EV) upgraded to Neutral from Sell at Citigroup... Eli Lilly (LLY) upgraded to Hold from Underperform at Jefferies... F5 Networks (FFIV) upgraded to Buy from Hold at Stifel... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Heartland Payment (HPY) upgraded to Hold from Sell at Stifel... Hyatt Hotels (H) upgraded to Outperform from Market Perform at FBR Capital... MasterCard (MA) upgraded to Outperform from Neutral at RW Baird... McDermott (MDR) upgraded to Neutral from Underweight at HSBC... Palo Alto (PANW) upgraded to Overweight at Stephens... PetroChina (PTR) upgraded to Neutral from Underperform at Credit Suisse... Seagate (STX) upgraded to Buy from Hold at Argus... Sensata (ST) upgraded to Buy from Neutral at Citigroup... Stryker (SYK) upgraded to Neutral from Reduce at SunTrust... TD Ameritrade (AMTD) upgraded to Buy from Neutral at UBS... TTM Technologies (TTMI) upgraded to Buy from Hold at Stifel... Transocean (RIG) upgraded to Hold from Sell at Deutsche Bank... VMware (VMW) upgraded to Outperform from Underperform at CLSA... Visa (V) upgraded to Outperform from Neutral at RW Baird... Yahoo (YHOO) upgraded to Buy from Neutral at SunTrust... Zimmer (ZMH) upgraded to Neutral from Reduce at SunTrust... bebe stores (BEBE) upgraded to Buy from Neutral at Janney Capital.
07:02 EDTCYHCommunity Health upgraded to Outperform from Perform at Oppenheimer
Subscribe for More Information
April 10, 2014
09:43 EDTCHSSeveral private equity firms interested in Chico's FAS, dealReporter says
April 8, 2014
15:54 EDTCHSChico's FAS up 6% after 2M share stake reported by Leonard Green Partners
Subscribe for More Information
15:48 EDTCHSLeonard Green discloses 2.05M share stake in Chico's FAS
Subscribe for More Information
11:11 EDTCHSChico's FAS management to meet with SunTrust
Subscribe for More Information
07:28 EDTFIRESecurity Innovation Network to hold a forum
IT Security Entrepreneurs Forum: ITSEF 2014 is being held in Mountain View, California on April 8-9.
April 4, 2014
08:43 EDTMDCOPointState Capital reports 7.3% passive stake in The Medicines Co.
Subscribe for More Information
April 3, 2014
07:05 EDTMDCOThe Medicines Co. announces FDA BLA acceptance for Fibrocaps,
The Medicines Co. announced that the U.S. Food and Drug Administration has accepted the filing of a biologic license application for the investigational hemostatic agent Fibrocaps, a dry powder formulation of fibrinogen and thrombin being developed to aid in hemostasis during surgery, where control of mild or moderate bleeding by conventional means is ineffective or impractical. The FDA action date for Fibrocaps is January 31, 2015.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use